Fundraising FoxRaNA Therapeutics
Cambridge, US · Founded 2012 · Delaware corporation · 3 known investors
Find your way into RaNA Therapeutics
Sign up to see every warm intro you have to RaNA Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RaNA Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RP
Robert PrentissExecutive
RC
Ronald C. Renaud, Jr.Executive
TM
Thomas McCauleyExecutive
Board
Investors · 3
M Ventureslisted by M VenturesAmsterdam · $10.8M
How we know: M Ventures's portfolio page · Not right? Tell us
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
Atlas VenturereportedCambridge · $500K – $1Mvia Jean-François Formela · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$162.3M disclosed across 3 rounds · 2015–2019
▶$47.5MraisedMay 2019 · 22 investors · BiotechnologyRule 506(b)
▶$47.5MraisedMay 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Francois FormelaDirector
- Daniella BeckmanDirector
- Robert M. PlengeDirector
- Richard WoosterExecutive Officer
- John R. SchroerExecutive Officer
- Michael HeartleinExecutive Officer
- Brian FentonExecutive Officer
- Paula CloghessyExecutive Officer
- Ronald Renaud, Jr.Executive Officer, Director
- Ann BarbierExecutive Officer
- Daniel S. LynchDirector
- Owen HughesDirector
- Robert J. MeyerDirector
- Paul BurgessExecutive Officer
- Offering amount
- $47.5M
- Amount sold
- $47.5M
- Sales commissions
- $2.8M
- Placement agents
- SVB Leerink LLC, Jefferies LLC
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$51MraisedJan 2017 · 25 investors · BiotechnologyRule 506(b)
▶$51MraisedJan 2017 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel LynchDirector
- Jean- Francois FormelaDirector
- Ronald Renaud, Jr.Executive Officer, Director
- Brian GallagherDirector
- Thomas McCauleyExecutive Officer
- Owen HughesDirector
- Offering amount
- $51M
- Amount sold
- $51M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$63.8MraisedJul 2015 · 27 investors · BiotechnologyRule 506(b)
▶$63.8MraisedJul 2015 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian GallagherDirector
- Jean Francois FormelaDirector
- Joshua ResnickDirector
- Robert PrentissExecutive Officer
- Daniel LynchDirector
- Ronald C. Renaud, Jr.Executive Officer, Director
- Offering amount
- $64.4M
- Amount sold
- $63.8M
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through RaNA Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are RaNA Therapeutics's investors?
- RaNA Therapeutics's investors include M Ventures, Pfizer Venture Investments, Atlas Venture.
- How much funding has RaNA Therapeutics raised?
- RaNA Therapeutics has disclosed $162.3M raised across 3 rounds.
- Where is RaNA Therapeutics headquartered?
- RaNA Therapeutics is headquartered in Cambridge, US.